MEDITCINSKY UNIVERSITET-PLOVDIV

Their core work

Medical University of Plovdiv is one of Bulgaria's leading medical universities, combining clinical education with growing research activity in chronic disease management and digital health. Their H2020 participation shows a clear shift from science outreach and public engagement toward substantive clinical research — particularly in managing complex conditions in elderly patients (atrial fibrillation, multimorbidity, polypharmacy) and AI-driven health monitoring. They bring clinical expertise and patient access from a major Bulgarian healthcare hub to European research consortia.

What they specialise in

How they've shifted over time

Between 2014 and 2020, Medical University-Plovdiv focused almost entirely on science outreach — running European Researchers' Night events that promoted interdisciplinary science, entrepreneurship, and public awareness in Bulgaria. From 2021 onward, the university pivoted sharply toward clinical health research, joining two substantial RIA projects on AI-powered health monitoring (iHELP) and integrated care for elderly patients with multiple conditions (AFFIRMO). This shift brought a dramatic increase in funding — from under EUR 30,000 across three outreach projects to over EUR 370,000 across two health research projects.

Moving decisively from science communication into clinical research partnerships, particularly in AI-assisted management of chronic conditions in aging populations — expect continued growth in digital health and personalized medicine.

How they like to work

Medical University-Plovdiv operates exclusively as a consortium participant — they have never coordinated an H2020 project. With 61 unique partners across 11 countries from just 5 projects, they join large, well-established consortia rather than leading small focused teams. This suggests they are a reliable contributing partner who brings regional clinical capacity and patient access to broader European efforts.

Despite only 5 projects, they have built a broad network of 61 partners across 11 countries, reflecting participation in large multi-partner consortia. Their geographic reach spans multiple EU member states, though their strongest connections likely run through Southern and Eastern European health research networks.

What sets them apart

As one of Bulgaria's top medical universities located in the country's second-largest city, they offer access to a large clinical population and healthcare infrastructure at competitive costs — a valuable asset for EU health projects needing diverse patient cohorts. Their dual background in science communication and clinical research means they can contribute both to the dissemination and the core research workpackages of health-focused consortia. For coordinators building health projects, they represent an experienced Bulgarian partner with a growing track record in digital health.

Highlights from their portfolio

• iHELP
  Their largest funded project (EUR 224,375) and a significant step into AI-powered personalised health monitoring and cancer research decision support.
• AFFIRMO
  A long-running project (2021-2026) tackling the clinically important intersection of atrial fibrillation, multimorbidity, and polypharmacy in elderly patients — their most medically substantive H2020 involvement.